Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Uriach describes potent and selective COX-2 inhibitors

Nov. 19, 2001

Phase II clinical results for 5G1.1 anticomplement antibody support further testing in RA

Nov. 19, 2001

DPC-333, a selective, orally active TACE inhibitor with potential in inflammation

Nov. 19, 2001

Orally active p38 MAP kinase effectively inhibits progression of collagen-induced arthritis

Nov. 19, 2001

Vertex invention provides p38 inhibitors, their production and use

Nov. 16, 2001

First in vivo data supporting selective inhibition of ERK1/2 in osteoarthritis therapy

Nov. 16, 2001

Kineret cleared for U.S. marketing, extensively covered at ACR/ARHP meeting

Nov. 16, 2001

Small-molecule Celgene/Serono IKK-2 inhibitors with disease-modifying antiarthritic activity

Nov. 16, 2001

AtheroGenics patents VCAM-1 expression inhibitors and potential uses

Nov. 15, 2001

COX-2-inhibitory pyrazole derivatives identified at Pfizer

Nov. 15, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...